Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 1/20 | 0.33 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.33 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.33 |
| ▸ | SGK1 | O00141 | 1/20 | 0.32 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.31 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.31 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.31 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.31 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.31 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.31 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.31 |
| ▸ | DHFR | P00374 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | RXRA | P19793 | 1/20 | 0.30 |
| ▸ | RXRB | P28702 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10028992 | 0.86 | RXRA (0.34) | RXRARXRB | |
| SCHEMBL10028997 | 0.86 | RXRA (0.34) | RXRARXRB | |
| SCHEMBL10029012 | 0.82 | MAPK9 (0.38) | CYP11B1CYP11B2SLC22A12MAPK9MAPK10 | |
| SCHEMBL16271347 | 0.81 | CYP1A2 (0.37) | MEN1KMT2ARXRARXRBKDM4E | |
| SCHEMBL10029011 | 0.80 | CYP11B1 (0.31) | CYP11B1 | |
| SCHEMBL10029004 | 0.80 | CYP11B1 (0.31) | CYP11B1 | |
| SCHEMBL12019896 | 0.79 | RXRA (0.36) | CYP11B1CYP11B2RXRARXRBKDM4E | |
| SCHEMBL12019775 | 0.79 | RXRA (0.36) | CYP11B1CYP11B2RXRARXRBKDM4E | |
| SCHEMBL24154500 | 0.78 | ESR1 (0.40) | CYP11B1SGK1CYP11B2RXRARXRB | |
| SCHEMBL15731083 | 0.78 | CYP11B1 (0.38) | ADORA2AADORA1CYP11B1CYP11B2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8586211-B2 | Asymmetrical aryl amine derivative for organic electroluminescence devices, method for preparing same, organic thin film for organic electroluminescence devices and organic electroluminescence device using same | DONGWOO FINE-CHEM CO. LTD. (KR) | 2013-11-19 | — | — | US | disclosed |
| US-20120032152-A1 | Asymmetrical Aryl Amine Derivative for Organic Electroluminescence Devices, Method for Preparing Same, Organic Thin Film for Organic Electroluminescence Devices and Organic Electroluminescence Device Using Same | DONGWOO FINE-CHEM CO. LTD. (KR) | 2012-02-09 | — | — | US | disclosed |
| US-20120032152-A1 | Asymmetrical Aryl Amine Derivative for Organic Electroluminescence Devices, Method for Preparing Same, Organic Thin Film for Organic Electroluminescence Devices and Organic Electroluminescence Device Using Same | DONGWOO FINE-CHEM CO. LTD. (KR) | 2012-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120032152-A1 | Asymmetrical Aryl Amine Derivative for Organic Electroluminescence Devices, Method for Preparing Same, Organic Thin Film for Organic Electroluminescence Devices and Organic Electroluminescence Device Using Same | AOC2, ALKBH2, ALKBH1 | ADORA2A 18/4885ADORA1 15/4885CYP11B1 2429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.